The Valley Desk

NCT06514742 · Interventional trial

A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant

Overall registry status Terminated

Phase 3

Conditions Anhedonia, Depressive Disorder, Major

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov